Highwoods Properties, Inc. (HIW) Tops Q1 FFO by 2c; Boosts FY12 FFO Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts HIW Hot Sheet
Price: $30.51 +0.13%
EPS Growth %: +83.3%
Financial Fact:
Total operating expenses: 121.41M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +83.3%
Financial Fact:
Total operating expenses: 121.41M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Highwoods Properties, Inc. (NYSE: HIW) reported Q1 FFO of $0.70, $0.02 better than the analyst estimate of $0.68. Revenue for the quarter came in at $129.94 million versus the consensus estimate of $128.7 million.
Highwoods Properties, Inc. sees FY2012 FFO of $2.60-$2.76, versus prior guidance of $2.56-$2.76 and the consensus of $2.67.
For earnings history and earnings-related data on Highwoods Properties, Inc. (HIW) click here.
Highwoods Properties, Inc. sees FY2012 FFO of $2.60-$2.76, versus prior guidance of $2.56-$2.76 and the consensus of $2.67.
For earnings history and earnings-related data on Highwoods Properties, Inc. (HIW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Accenture shares fall on insider sales and analyst downgrade
- BioNTech and Bristol Myers Squibb report Phase 2 data for pumitamig in NSCLC
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
